Literature DB >> 27482514

Low bone mineral density and associated risk factors in HIV-infected patients.

Cristina-Emilia Chiţu-Tișu1, Ecaterina-Constanţa Barbu1, Mihai Lazăr2, Daniela Adriana Ion3, Ioana Anca Bădărău4.   

Abstract

BACKGROUND: Aging of persons with human immunodeficiency virus (HIV) resulted in high rates of osteopenia and osteoporosis. Multiple cohort studies have reported an increased prevalence of bone demineralization among HIV-infected individuals. The aim of this study was to evaluate bone mineral density (BMD) and risk factors for osteopenia/osteoporosis among HIV-positive patients attending the National Institute for Infectious Diseases "Prof.Dr. Matei Balș", Bucharest, Romania.
METHODS: We performed a cross-sectional study that enrolled 60 patients with HIV. The association between BMD and lifestyle habits (smoking), body mass index (BMI), nadir cluster of differentiation 4 (CD4) cell count, current CD4 cell count, HIV viral load and history of combination antiretroviral therapy (cART) were investigated. The BMD was measured at the lumbar spine, hips and total body using dual-energy X-ray absorptiometry (DEXA).
RESULTS: In the present study, DEXA evaluation showed an overall prevalence of osteoporosis of 16.66% (ten patients) and a prevalence of osteopenia of 48.33% (29 patients). In men, low BMI and cigarette smoking showed significant association with the diagnosis of lumbar spine demineralization (p=0.034 and p=0.041, respectively). Duration of exposure to cART classes in relation to BMD was also evaluated. The use of non-nucleoside reverse-transcriptase inhibitors (NNRTIs) was associated with low lumbar spine BMD in all patients (p=0.015). Reduced BMD was significantly associated with protease inhibitors (PIs)-containing treatment (p=0.043) in women.
CONCLUSION: At lumbar spine DEXA, male gender was statistically associated with reduced BMD. At the left hip Ward's area, decreased BMD T scores were significantly associated with aging. The reduced BMD was higher in patients receiving PI- or NNRTI-containing regimens.

Entities:  

Keywords:  HIV; antiretroviral therapy; bone mineral density; osteopenia; osteoporosis

Year:  2016        PMID: 27482514      PMCID: PMC4956161          DOI: 10.11599/germs.2016.1089

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  26 in total

1.  Osteopenia in HIV-infected patients: is it the disease or is it the treatment?

Authors:  H Knobel; A Guelar; G Vallecillo; X Nogués; A Díez
Journal:  AIDS       Date:  2001-04-13       Impact factor: 4.177

2.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

3.  Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy.

Authors:  Adrian Curran; Esteban Martinez; Maria Saumoy; Luis del Rio; Manuel Crespo; Maria Larrousse; Daniel Podzamczer; Joaquin Burgos; Montse Lonca; Pere Domingo; Jose Maria Gatell; Esteban Ribera
Journal:  AIDS       Date:  2012-02-20       Impact factor: 4.177

Review 4.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

Authors: 
Journal:  Am J Med       Date:  1993-06       Impact factor: 4.965

5.  Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.

Authors:  A Carr; J Miller; J A Eisman; D A Cooper
Journal:  AIDS       Date:  2001-04-13       Impact factor: 4.177

Review 6.  CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis.

Authors:  Mark J Bolland; Andrew B Grey; Greg D Gamble; Ian R Reid
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

Review 7.  Bone disease in the setting of HIV infection: update and review of the literature.

Authors:  D Castronuovo; B Cacopardo; M R Pinzone; M Di Rosa; F Martellotta; O Schioppa; S Moreno; G Nunnari
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-09       Impact factor: 3.507

8.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

9.  Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.

Authors:  Todd T Brown; Grace A McComsey; Martin S King; Roula B Qaqish; Barry M Bernstein; Barbara A da Silva
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.771

10.  Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.

Authors:  Ozlem Altuntas Aydın; Hayat Kumbasar Karaosmanoglu; Rıdvan Karahasanoglu; Meryem Tahmaz; Ozcan Nazlıcan
Journal:  Braz J Infect Dis       Date:  2013-09-25       Impact factor: 3.257

View more
  11 in total

1.  Low bone mass and vitamin D in Brazilian people living with HIV under antiretroviral therapy.

Authors:  Juliana Mendes Abreu; Amanda B B Nogueira; Mariana M Villela; Denise M Módolo; Thaís C Panaro; Sérgio Setubal; Luiz Guillermo C Velarde; Giovanna A B Lima; Rubens A da Cruz Filho; Debora V Soares
Journal:  Arch Osteoporos       Date:  2022-03-05       Impact factor: 2.617

2.  Effects of maximal strength training on bone mineral density in people living with HIV and receiving anti-retroviral therapy: a pilot study.

Authors:  Enock M Chisati; Demitri Constantinou; Fanuel Lampiao
Journal:  BMC Sports Sci Med Rehabil       Date:  2020-10-23

3.  Morphine Potentiates Dysbiotic Microbial and Metabolic Shifts in Acute SIV Infection.

Authors:  Gregory M Sindberg; Shannon E Callen; Santanu Banerjee; Jingjing Meng; Vanessa L Hale; Ramakrishna Hegde; Paul D Cheney; Francois Villinger; Sabita Roy; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-21       Impact factor: 4.147

4.  HYPOVITAMINOSIS D IN HIV-INFECTED PATIENTS.

Authors:  C Poiana; C Capatina; Anca Streinu Cercel; O Sandulescu; A Streinu Cercel
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

5.  BONE QUALITY IN A YOUNG COHORT OF HIV-POSITIVE PATIENTS.

Authors:  A R Negru; C Tiliscan; A M Tudor; D I Munteanu; C Popescu; M Lazar; A Streinu-Cercel; V Arama; S S Arama
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Oct-Dec       Impact factor: 0.877

Review 6.  Management of Reduced Bone Mineral Density in HIV: Pharmacological Challenges and the Role of Exercise.

Authors:  Enock M Chisati; Demitri Constantinou; Fanuel Lampiao
Journal:  Front Physiol       Date:  2018-08-07       Impact factor: 4.566

7.  Quantitative ultrasonometry: An alternative and easy method to evaluate bone quality in people living with human immunodeficiency virus.

Authors:  Elena Segal; Gamal Hassoun; Carcom Maor; Eduardo Shahar
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-03-01       Impact factor: 2.041

8.  Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors.

Authors:  Enock M Chisati; Demitri Constantinou; Fanuel Lampiao
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

9.  Low bone mineral density among HIV-infected patients in Brazil.

Authors:  Daniela Cardeal da Silva Chaba; Lisméia R Soares; Rosa M R Pereira; George W Rutherford; Tatiane Assone; Liliam Takayama; Luiz A M Fonseca; Alberto J S Duarte; Jorge Casseb
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-12-21       Impact factor: 1.846

10.  HIV Infection and Bone Abnormalities.

Authors:  Aamir N Ahmad; Shahid N Ahmad; Nafees Ahmad
Journal:  Open Orthop J       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.